ELIGLUSTAT TARTRATE
| Brand name | CERDELGA |
|---|---|
| Active ingredient | ELIGLUSTAT TARTRATE |
| Strength | EQ 84MG BASE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | August 2014 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10888544 | December 2038 | use U-3040 |
| 12465586 | June 2032 | use U-3043 |
| 10888547 | January 2031 | use U-3043 |
| 11458119 | November 2030 | substance, product |
| 7196205 | June 2026 | substance |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.